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Hypothalamic POMCneurons contribute to the regulation of energy homeostasis and glucosemetabolism. In
this issue of Neuron, Yang et al. (2012) show that the mTOR pathway has a pivotal role in deterioration of
POMC neurons during age-dependent obesity.Obesity is a risk factor in age-related
metabolic diseases including type 2 dia-
betes, cancer, and cardiovascular and
neurodegenerative diseases. However,
mechanisms explaining age-dependent
changes in the central regulation of
metabolism that result in obesity are
not understood. It has been suggested
that hypothalamic pro-opiomelanocortin
(POMC) neurons, which are critical regu-
lators of energy homeostasis and glucose
metabolism, may play important roles in
the etiology of chronological age-associ-
ated metabolic and neurodegenerative
disorders (Xu et al., 2005; Halabe Bucay,
2008). Mammalian target of rapamycin
(mTOR) is the target of rapamycin and
a serine/threonine protein kinase that
regulates cell growth, proliferation, and
motility. Over the last decade, many labo-
ratories focused on mTOR signaling to
better understand the aging process and
to develop antiaging strategies. Hypotha-
lamic mTOR signaling was also found to
be relevant for feeding behavior and
peripheral metabolism through mediating
signaling of nutrients and hormones (Cota
et al., 2006; Mori et al., 2009). In this issue
of Neuron, Yang et al. (2012) provide
evidence that increased mTOR signaling
in POMC neurons of the hypothalamic
arcuate nucleus plays a crucial role in
the development of age-dependent
obesity.
POMC neurons, together with another
population of arcuate nucleus neurons
that coproduce neuropeptide Y (NPY),
agouti-related protein (AgRP), and
GABA, control food intake, energy expen-
diture, and glucose homeostasis. They
project to various brain sites, such as
the paraventricular hypothalamic nucleus,
where they regulate melanocortin-4
receptor (MC4R) function. When elevated356 Neuron 75, August 9, 2012 ª2012 Elsevileptin and glucose levels trigger POMC
neurons to fire, they secrete melanocyte-
stimulating hormone (a-MSH). Food
intake decreases, energy expenditure
increases, and peripheral glucose metab-
olism is enhanced. When glucose and
leptin levels decline during fasting or
times of low food availability, NPY/AgRP
neurons become active and POMC
neurons become silent. Consequently,
appetite increases, energy expenditure
subsides, and lipid metabolism is favored
over glucose utilization. a-MSH released
from POMC cells is an agonist of the
MC4R, while AgRP is an inverse agonist
of MC4R. Activation and inactivation of
MC4R in the paraventricular hypotha-
lamic nucleus is an important regulator
of feeding.
Yang et al. (2012) demonstrate that
POMC neurons deteriorate in aged mice
that display obesity (Figure 1). POMC
neurons have diminished neuronal firing
and a-MSH secretion. In order to clarify
whether POMC neuronal silencing in
these animals can be influenced by
synaptic inputs, they evaluated the
resting potential and action potential firing
of POMC neurons after blockade of
glutamate and GABA receptors. They
identified that when an ATP-sensitive
potassium (KATP) channel blocker was
present, depolarization of POMC neurons
in aged mice was restored, suggesting
that age-dependent deterioration of
POMC neuron firing is associated with
KATP channel activation.
One of the striking findings of Yang
et al. (2012) is that mTOR activity was
elevated in POMC neurons of the aged
mice, leading to cell hypertrophy. Since
increased mTOR signaling gives rise to
hypertrophy of neuronal cells (Meikle
et al., 2008), their observation suggestser Inc.that cell hypertrophy and obesity-related
deterioration of POMC neurons might be
causally related. The work of Yang et al.
(2012) built on a previous report
describing a role for mTOR signaling in
the control of POMC neurons (Mori
et al., 2009). Mori et al. (2009) evaluated
the effects of deleting the Tsc1 gene,
which is a major upstream inhibitor of
mTOR. They demonstrated that elevation
of mTOR signaling in POMC neurons re-
sulted in enlarged POMC neuron somas
and reduced neurite projections to the
PVN (Mori et al., 2009). Plum et al. (2006)
also reported that inactivation of POMC
neurons by POMC-specific deletion of
PTEN, a lipid phosphatase that inacti-
vates KATP channel by decreasing PIP3
content, resulted in hypertrophy of
POMC cells (Plum et al., 2006). In the
current paper, Yang et al. (2012) extend
these findings to implicate mTOR in age-
induced deterioration of POMC neurons
leading to hyperphagic obesity. Neverthe-
less, it remains unclear how hypertrophy
of POMC neurons leads to dysregulation
of neuronal projections and neurotrans-
mitter release and what the intracellular
and extracellular triggers of this process
are. An intriguing recent finding was the
observation of peroxisome proliferation
in POMC neurons associated with diet-
induced obesity (Diano et al., 2011). This
process is related to glucose and lipid
overload to POMC neurons (Diano et al.,
2011), which is also a fundamental
prerequisite of cellular growth. In that
case, reversal of peroxisome proliferation
resulted in restoration of POMC neuronal
firing by enhancing generation of reactive
oxygen species (Diano et al., 2011). Thus,
it is possible that mTOR-related cellular
growth of POMC neurons may also impair
cellular metabolism and ROS control.
Figure 1. Contribution of mTOR to Age-Induced Deterioration of
POMC Neurons
Activation of mTOR signaling in aging mice leads to hyperphagic obesity by
triggering deterioration of POMC neurons. Neuronal somas become hypertro-
phic, neurite projections to the PVN are impaired, and neuronal activity and
leptin-induced secretion of a-MSH is diminished. KATP channels play a crucial
role in age-induced silencing of POMC neurons by controlling membrane
potential of these cells. Rapamycin, a blocker of mTOR, restores cell size
and activity of POMC cells.
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PreviewsYang et al. (2012) explored
whether constant elevation of
mTOR signaling in either
POMC neurons or NPY/AgRP
neurons may lead to obesity
or weight loss using an
elegantly designed mouse
model. To accomplish cell-
selective upregulation of
mTOR signaling in either of
these cell populations, they
crossed POMC-Cre or AgRP-
Cre mice with floxed TSC1
mice. TSC1 is a negative regu-
lator of mTOR; hence, its cell-
specific knockdown in either
POMC or AgRP neurons
would lead to chronically
elevated mTOR signaling in
these cells. They confirmed
the findings of Mori et al.
(2009), showing that elevation
of mTOR signaling induced
by deletion of the Tsc1 gene
in POMC neurons silenced
POMC neuron activity and re-
sulted in hyperphagic obesityeven in young mice. Intriguingly, however,
deletion of the Tsc1 gene in NPY/AgRP
neurons had no effect on the firing rate
and soma size of these neurons. They
further corroborated these findings by
investigating the effect of intracerebral
infusion of rapamycin, an inhibitor of
mTOR signaling, on metabolic phenotype
and neuronal activity. Rapamycin has
been proposed as a putative promoter of
longevity and suppressor of metabolic
disorders and neurodegenerative dis-
eases such as Alzheimer’s and Parkin-
son’s diseases. Central administration of
rapamycin rescued silencing and hyper-
trophy of POMC neurons during chrono-
logical aging and suppressed age-depen-
dent obesity. On the other hand,
consistent with patterns of the conditional
KO mice deleting Tsc1 gene in NPY/
AgRP neurons, rapamycin had no effect
on NPY/AgRP neuronal activity. One
possible explanation for the ‘‘insensitivity’’
of NPY/AgRP neurons to rapamycin is
that NPY/AgRP neurons may be more
reliant on other intracellular pathways for
their firing, such as fatty acid metabolism
(Andrews et al., 2008).
To elucidate an underlying mechanism
for the observed phenomenon, Yang
et al. (2012) revealed a contribution ofKATP channel activity in the age-related
silencing of POMC neurons. Elimination
of the Tsc1 gene in POMC neurons of
young mice gave rise to the elevation of
KATP channel activity. Increased KATP
channel activity leads to potassium
outflow from the neurons, resulting in
hyperpolarization of membrane potential.
This effect, in turn, can lead to silencing
of POMC neurons and consequent dimin-
ished a-MSH release even in the pres-
ence of elevated leptin levels. Because
a-MSH is the critical activator of MC4
receptors that promote satiety, impaired
release of this peptide, by default, will
promote feeding.
Glucose intolerance and insulin resis-
tance are common symptoms of type 2
diabetes and are closely linked to body
mass index (BMI). Yang et al. (2012)
observed a discrepancy in the relation-
ship between BMI and glucose intoler-
ance in POMC-specific Tsc1 KO mice.
They argue that specific activation of
KATP channels in POMC neurons may
improve glucose metabolism, because
a previous study described that hypotha-
lamic activation of KATP channels can,
under very specific circumstances, lead
to enhanced glucose metabolism (Pocai
et al., 2005). However, studies haveNeuron 75, August 9shown that there is positive
interaction between POMC
neuron activity and glucose
metabolism regardless of
feeding behavior and
adiposity (Berglund et al.,
2012). Thus, more studies
are needed to reconcile these
differential effects. Whether
the observations of Yang
et al. (2012) could lead to the
development of successful
strategies to interfere with
age-associated metabolic im-
pairments will be answered in
the future.REFERENCES
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